114 related articles for article (PubMed ID: 18256527)
1. Basal c-Jun N-terminal kinases promote mitotic progression through histone H3 phosphorylation.
Lee K; Song K
Cell Cycle; 2008 Jan; 7(2):216-21. PubMed ID: 18256527
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of cell proliferation and cell cycle progression by specific inhibition of basal JNK activity: evidence that mitotic Bcl-2 phosphorylation is JNK-independent.
Du L; Lyle CS; Obey TB; Gaarde WA; Muir JA; Bennett BL; Chambers TC
J Biol Chem; 2004 Mar; 279(12):11957-66. PubMed ID: 14704147
[TBL] [Abstract][Full Text] [Related]
3. The c-Jun N-terminal kinase JNK functions upstream of Aurora B to promote entry into mitosis.
Oktay K; Buyuk E; Oktem O; Oktay M; Giancotti FG
Cell Cycle; 2008 Feb; 7(4):533-41. PubMed ID: 18431843
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of mixed-lineage kinase (MLK) activity during G2-phase disrupts microtubule formation and mitotic progression in HeLa cells.
Cha H; Dangi S; Machamer CE; Shapiro P
Cell Signal; 2006 Jan; 18(1):93-104. PubMed ID: 15923109
[TBL] [Abstract][Full Text] [Related]
5. c-Jun N-terminal kinase/c-Jun inhibits fibroblast proliferation by negatively regulating the levels of stathmin/oncoprotein 18.
Yeap YY; Ng IH; Badrian B; Nguyen TV; Yip YY; Dhillon AS; Mutsaers SE; Silke J; Bogoyevitch MA; Ng DC
Biochem J; 2010 Sep; 430(2):345-54. PubMed ID: 20594188
[TBL] [Abstract][Full Text] [Related]
6. Histone H3 phosphorylation at serine 10 and serine 28 is mediated by p38 MAPK in rat hepatocytes exposed to ethanol and acetaldehyde.
Lee YJ; Shukla SD
Eur J Pharmacol; 2007 Nov; 573(1-3):29-38. PubMed ID: 17643407
[TBL] [Abstract][Full Text] [Related]
7. c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia.
Waetzig V; Czeloth K; Hidding U; Mielke K; Kanzow M; Brecht S; Goetz M; Lucius R; Herdegen T; Hanisch UK
Glia; 2005 May; 50(3):235-46. PubMed ID: 15739188
[TBL] [Abstract][Full Text] [Related]
8. Mitotic histone H3 phosphorylation by vaccinia-related kinase 1 in mammalian cells.
Kang TH; Park DY; Choi YH; Kim KJ; Yoon HS; Kim KT
Mol Cell Biol; 2007 Dec; 27(24):8533-46. PubMed ID: 17938195
[TBL] [Abstract][Full Text] [Related]
9. Involvement of histone H3 phosphorylation through p38 MAPK pathway activation in casticin-induced cytocidal effects against the human promyelocytic cell line HL-60.
Kikuchi H; Yuan B; Yuhara E; Takagi N; Toyoda H
Int J Oncol; 2013 Dec; 43(6):2046-56. PubMed ID: 24064676
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of serine-10 of histone H3 shields modified lysine-9 selectively during mitosis.
Jeong YS; Cho S; Park JS; Ko Y; Kang YK
Genes Cells; 2010 Mar; 15(3):181-92. PubMed ID: 20070858
[TBL] [Abstract][Full Text] [Related]
11. Cot, a novel kinase of histone H3, induces cellular transformation through up-regulation of c-fos transcriptional activity.
Choi HS; Kang BS; Shim JH; Cho YY; Choi BY; Bode AM; Dong Z
FASEB J; 2008 Jan; 22(1):113-26. PubMed ID: 17724252
[TBL] [Abstract][Full Text] [Related]
12. JNK1 regulates histone acetylation in trigeminal neurons following chemical stimulation.
Wu J; Zhang X; Nauta HJ; Lin Q; Li J; Fang L
Biochem Biophys Res Commun; 2008 Nov; 376(4):781-6. PubMed ID: 18822271
[TBL] [Abstract][Full Text] [Related]
13. The topoisomerase II inhibitor VM-26 induces marked changes in histone H1 kinase activity, histones H1 and H3 phosphorylation, and chromosome condensation in G2 phase and mitotic BHK cells.
Roberge M; Th'ng J; Hamaguchi J; Bradbury EM
J Cell Biol; 1990 Nov; 111(5 Pt 1):1753-62. PubMed ID: 2172257
[TBL] [Abstract][Full Text] [Related]
14. Mitotic histone H3 phosphorylation by the NIMA kinase in Aspergillus nidulans.
De Souza CP; Osmani AH; Wu LP; Spotts JL; Osmani SA
Cell; 2000 Aug; 102(3):293-302. PubMed ID: 10975520
[TBL] [Abstract][Full Text] [Related]
15. IGF-I plus E2 induces proliferation via activation of ROS-dependent ERKs and JNKs in human breast carcinoma cells.
Lin CW; Yang LY; Shen SC; Chen YC
J Cell Physiol; 2007 Sep; 212(3):666-74. PubMed ID: 17458902
[TBL] [Abstract][Full Text] [Related]
16. Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential.
Bogoyevitch MA; Boehm I; Oakley A; Ketterman AJ; Barr RK
Biochim Biophys Acta; 2004 Mar; 1697(1-2):89-101. PubMed ID: 15023353
[TBL] [Abstract][Full Text] [Related]
17. Selective repression of low-density lipoprotein receptor expression by SP600125: coupling of histone H3-Ser10 phosphorylation and Sp1 occupancy.
Huang W; Batra S; Korrapati S; Mishra V; Mehta KD
Mol Cell Biol; 2006 Feb; 26(4):1307-17. PubMed ID: 16449644
[TBL] [Abstract][Full Text] [Related]
18. Galloyl benzamide-based compounds modulating tumour necrosis factor α-stimulated c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signalling pathways.
Leo V; Stefanachi A; Nacci C; Leonetti F; de Candia M; Carotti A; Altomare CD; Montagnani M; Cellamare S
J Pharm Pharmacol; 2015 Oct; 67(10):1380-92. PubMed ID: 26078032
[TBL] [Abstract][Full Text] [Related]
19. Evidence for JNK-dependent up-regulation of proteoglycan synthesis and for activation of JNK1 following cyclical mechanical stimulation in a human chondrocyte culture model.
Zhou Y; Millward-Sadler SJ; Lin H; Robinson H; Goldring M; Salter DM; Nuki G
Osteoarthritis Cartilage; 2007 Aug; 15(8):884-93. PubMed ID: 17408985
[TBL] [Abstract][Full Text] [Related]
20. Trivalent dimethylarsenic compound induces histone H3 phosphorylation and abnormal localization of Aurora B kinase in HepG2 cells.
Suzuki T; Miyazaki K; Kita K; Ochi T
Toxicol Appl Pharmacol; 2009 Dec; 241(3):275-82. PubMed ID: 19716834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
